OTC naloxone is a baby step toward making the life-saving medication accessible
Critiquing profiteering by naloxone manufacturers and proposing solutions to fix this issue.
OTC naloxone is a baby step toward making the life-saving medication accessible
Critiquing profiteering by naloxone manufacturers and proposing solutions to fix this issue.
Jonathan JK Stoltman, PhD is Director of the Opioid Policy Institute. They have been an addiction scientist since 2013. Their work has appeared in leading academic journals and in the media.
All articles